Nymox Pharmaceutical
NYMX
#9971
Rank
A$28.7 M
Marketcap
Country
$0.31
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$10.27 Million, an increase over its 2021 earnings that were of -A$19.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-67.4%
2022 -A$10.27 Million-47.71%
2021 -A$19.63 Million6.61%
2020 -A$18.41 Million-10.91%
2019 -A$20.67 Million24.24%
2018 -A$16.64 Million-20.03%
2017 -A$20.8 Million2.71%
2016 -A$20.25 Million-63.86%
2015 -A$56.04 Million674.44%
2014 -A$7.24 Million-6.11%
2013 -A$7.71 Million-35.66%
2012 -A$11.98 Million-20.76%
2011 -A$15.12 Million38.33%
2010 -A$10.93 Million35.59%
2009 -A$8.06 Million11.8%
2008 -A$7.21 Million-12.94%
2007 -A$8.28 Million8.85%
2006 -A$7.61 Million36.5%
2005 -A$5.58 Million-4.4%
2004 -A$5.83 Million-14.58%
2003 -A$6.83 Million
2001 -A$5.01 Million-20.54%
2000 -A$6.31 Million21.72%
1999 -A$5.18 Million-25.56%
1998 -A$6.96 Million101.3%
1997 -A$3.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.02 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.47 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.84 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.94 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.42 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA